The board of the Hyderabad-based pharmaceutical company also recommended a final dividend of ₹30 per share for FY26.

Firms including Rainbow Children's Medicare, Anupam Rasayan India, Dollar Industries, Polyplex, and Precision Wires are also ...

Stay updated with the Divis Labs Stock Liveblog, your one-stop destination for real-time information and analysis of a ...

Divi's Laboratories Q4 Results: Divi's Laboratories announced strong financial results for the March quarter. Net profit rose ...

Divis Laboratories Ltd is quoting at Rs 6722, up 1.07% on the day as on 12:49 IST on the NSE. The stock is up 9.34% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the ...

Ashis Biswas, Head of Technical Research at CapitalVia Global Research highlights Fundamentals and Technical Analysis on Divi ...

NTPC, Divi's Laboratories, JK Cement, and Reliance Infrastructure are among the companies to report Q4 earnings today.

Divis Lab trading at ₹3260.15, down -0.56% from yesterday's ₹3278.6 As of the current data, the price of Divis Lab stock is ₹3260.15, indicating a decline of 0.56% from the previous trading day. The ...

Divis Labs’ revenue for the quarter amounted to Rs. 2,238 crore, marking a 17% y-o-y increase and a 6% q-o-q rise, which was 4% above estimates. EBITDA stood at Rs. 616 crore, reflecting a 29% y-o-y ...

Divis Laboratories’ net profit declined 29 percent at ₹348 crore in the second quarter of the current financial year ended September 30, 2023, against ₹493 crore in the corresponding quarter of the ...

Drug-maker Divis Laboratories is likely to post a net profit of around ₹420 crore in the second quarter ended September 30, 2023 as against ₹493 crore earned in the corresponding quarter of the last ...

Divis Lab trading at ₹3292.95, up 0.5% from yesterday's ₹3276.5 As of the latest trading day, Divis Lab's stock has a current price of ₹3292.95, which represents a 0.5% increase from the previous ...